한글목차

레지오넬라 테스트 키트 시장

레지오넬라 테스트 키트 시장은 2023년 3억 2,400만 달러로 평가되었고, 2024년부터 2033년까지 연평균 7.7% 성장하여 2033년에는 6억 8,450만 달러에 이를 것으로 예상됩니다.

레지오넬라 테스트 키트는 레지오넬라균을 검출할 수 있는 빠른 DIY 테스터입니다. 이 키트는 기본적으로 요양시설, 병원, 접객업, 수영장, 분수대, 냉각탑 등의 공간에서 사용됩니다. 검사는 배양법, 중합효소 연쇄반응법, 면역학적 분석 등 다양한 생체 분자 공정을 통해 이루어집니다. 키트의 주요 특징은 빠른 납기, 높은 정확도, 사용 편의성 등입니다.

수인성 전염병 예방에 대한 인식이 높아지면서 레지오넬라 테스트 키트 시장의 주요 촉진요인으로 작용하고 있습니다. 상업 및 공공시설에서 공공 안전에 대한 규제가 강화되면서 검사 키트의 채택을 촉진하고 있습니다. 또한, 기술 발전은 검사 키트의 효과와 신뢰성을 향상시켜 시장 개척을 촉진하고 있습니다. 최근에는 검사 결과의 신속한 제공과 디지털 솔루션과의 통합이 두드러진 추세입니다. 검사 결과의 원활한 분석과 보고를 용이하게 하기 위해 제조업체들은 디지털 데이터 관리 시스템과 통합할 수 있는 키트를 설계하고 있습니다. 이러한 통합은 수질 및 안전 패턴을 추적하고 효과적인 의사결정을 내리는 데 도움이 됩니다.

그러나 고정밀, 정밀도가 높은 고급 버전의 키트 비용은 여전히 상당히 높기 때문에 소규모 조직에서는 구매가 제한되어 있습니다. 또한 샘플을 채취하고 키트를 취급하는 것은 복잡한 과정이며 훈련과 연습이 필요합니다. 키트의 약간의 오염은 신뢰성에 영향을 미치고 시장 성장을 방해합니다. 반대로 공공 장소와 건물에 대한 정기적인 수질 검사를 실시하려는 정부의 이니셔티브는 시장에 유리한 기회를 제공합니다. 예를 들어, 미국에서는 2024년 1월에 연방 정부의 여러 건물에서 수질 검사를 실시하여 건물을 방문하거나 건물에서 일하는 사람들의 건강을 보장합니다.

부문별 리뷰

레지오넬라 테스트 키트 시장은 유형, 최종 사용자, 지역으로 분류됩니다. 유형별로 시장은 배양액, 소변 항원 검사, 중합효소 연쇄반응, 혈청학, 직접 형광 항체 검사로 나뉩니다. 최종사용자 기준으로는 병원 및 클리닉, 임상 실험실, 기타로 분류됩니다. 지역별로는 북미, 유럽, 아시아태평양, LAMEA로 분석됩니다.

주요 조사 결과

유형별로는 중합효소 연쇄반응 부문이 2023년 가장 큰 점유율을 차지했습니다.

최종 사용자별로는 병원 및 클리닉 부문이 2023년 시장에서 높은 점유율을 차지했습니다.

지역별로는 북미가 2023년 가장 높은 수익을 올릴 것으로 예상됩니다.

본 보고서에서 가능한 커스터마이징(추가 비용 및 일정이 있습니다.)

• 고객의 관심사에 따른 기업 프로파일 추가

목차

제1장 서론

제2장 주요 요약

제3장 시장 구도

• 시장 정의와 범위
• 주요 조사 결과
  • 주요 투자 기회
  • 주요 성공 전략
• Porter의 Five Forces 분석
• 시장 역학
  • 성장 촉진요인
  • 성장 억제요인
  • 기회

제4장 레지오넬라 테스트 키트 시장 : 유형별

• 시장 개요
• 배양 배지
• 소변 항원 검사
• 중합효소 연쇄반응
• 혈청 검사
• 직접 형광 항체 검사

제5장 레지오넬라 테스트 키트 시장 : 최종사용자별

• 시장 개요
• 병원 및 진료소
• 임상 실험실
• 기타

제6장 레지오넬라 테스트 키트 시장 : 지역별

• 시장 개요
• 북미
  • 주요 시장 동향과 기회
  • 미국 레지오넬라 테스트 키트 시장
  • 캐나다 레지오넬라 테스트 키트 시장
  • 멕시코 레지오넬라 테스트 키트 시장
• 유럽
  • 주요 시장 동향과 기회
  • 프랑스 레지오넬라 테스트 키트 시장
  • 독일 레지오넬라 속균 검사 키트 시장
  • 이탈리아 레지오넬라 속균 검사 키트 시장
  • 스페인 레지오넬라 속균 검사 키트 시장
  • 영국 레지오넬라 테스트 키트 시장
  • 기타 유럽 레지오넬라 테스트 키트 시장
• 아시아태평양
  • 주요 시장 동향과 기회
  • 중국 레지오넬라 속균 검사 키트 시장
  • 일본 레지오넬라 속균 검사 키트 시장
  • 인도 레지오넬라 속균 검사 키트 시장
  • 한국 레지오넬라 테스트 키트 시장
  • 호주 레지오넬라 테스트 키트 시장
  • 기타 아시아태평양 레지오넬라 테스트 키트 시장
• 라틴아메리카/중동 및 아프리카
  • 주요 시장 동향과 기회
  • 브라질 레지오넬라 속균 검사 키트 시장
  • 남아프리카공화국 레지오넬라 속균 검사 키트 시장
  • 사우디아라비아 레지오넬라 속균 검사 키트 시장
  • 기타 라틴아메리카/중동 및 아프리카 레지오넬라 속균 검사 키트 시장

제7장 경쟁 구도

• 서론
• 주요 성공 전략
• 주요 10개 기업의 제품 매핑
• 경쟁 대시보드
• 경쟁 히트맵
• 주요 기업의 포지셔닝(2023년)

제8장 기업 개요

• IDEXX Laboratories, Inc.
• Thermo Fisher Scientific
• Merck Group KGaA
• Pall Corporation
• Bio-Rad Laboratories, Inc.
• Abbott Laboratories
• Hygiena
• Veolia Water Technologies
• Pro-Lab Diagnostics
• Phigenics, LLC

영문목차

Legionella Testing Kits Market

The legionella testing kits market was valued at $324.0 million in 2023 and is projected to reach $684.5 million by 2033, growing at a CAGR of 7.7% from 2024 to 2033.

A legionella testing kit is a rapid do-it-yourself tester which enables detection of the bacteria Legionella. This kit is essentially used in spaces such as care homes & hospitals, hospitality, pools & fountains, and cooling towers. The testing is performed using diverse biomolecular processes such as culture method, polymerase chain reaction technique, or immunological assay. The key attributes of the kit include short turnaround time, high precision, and ease of usage.

Increase in awareness about the prevention of water borne diseases is a key driver of the legionella testing kits market. Commercial and public buildings have strengthened their regulations regarding public safety, boosting the adoption of testing kits. In addition, advancements in technology have enhanced the efficacy and reliability of the kits, thereby augmenting the development of the market. In recent times, quick delivery of results and integration of the kits with digital solutions are the prominent trends acquiring traction. To facilitate seamless analysis and reporting of test results, manufacturers are designing kits with the ability to be assimilated with digital data management systems. This integration assists in tracking the patterns of water quality & safety and making effective decisions.

However, the cost of advanced version of kits with high precision and accuracy remains significantly high, restricting small organizations from purchasing them. Furthermore, the collection and handling of the sample & kit is a complex process which requires training & practice. Slight contamination of the kit impacts its reliability, thereby hampering the growth of the market. Contrarily, efforts by governments to conduct periodic water testing in public places and buildings are presenting lucrative opportunities for the market. For instance, the U.S. General Service Administration conducted water testing across several federal buildings in January 2024 to ensure the wellness of individuals visiting and working in the buildings.

Segment Review

The legionella testing kits market is segmented into type, end user, and region. On the basis of type, the market is divided into culture media, urine antigen testing, polymerase chain reaction, serology, and direct fluorescent antibody test. Depending on end user, it is classified into hospitals & clinics, clinical laboratories, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

On the basis of type, the polymerase chain reaction segment accounted for the largest share in 2023.

Depending on end user, the hospitals & clinics segment acquired a high stake in the market in 2023.

Region wise, North America was the highest revenue generator in 2023.

Competition Analysis

The leading players operating in the global legionella testing kits market include IDEXX Laboratories, Inc., Thermo Fisher Scientific, Merck Group KGaA, Pall Corporation, Bio-Rad Laboratories, Inc., Abbott Laboratories, Hygiena, Veolia Water Technologies, Pro-Lab Diagnostics, and phigenics, llc. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships, to strengthen their foothold in the competitive market.

Additional benefits you will get with this purchase are:

• Quarterly Update and* (only available with a corporate license, on listed price)
• 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
• Free Upcoming Version on the Purchase of Five and Enterprise User License.
• 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
• 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
• Free data Pack on the Five and Enterprise User License. (Excel version of the report)
• Free Updated report if the report is 6-12 months old or older.
• 24-hour priority response*
• Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

• Additional company profiles with specific to client's interest

Key Market Segments

By Type

• Culture Media
• Urine Antigen Testing
• Polymerase Chain Reaction
• Serology
• Direct Fluorescent Antibody Test

By End User

• Hospitals and Clinics
• Clinical Laboratories
• Others

By Region

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • France
  • Germany
  • Italy
  • Spain
  • UK
  • Rest of Europe
• Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia-Pacific
• LAMEA
  • Brazil
  • South Africa
  • Saudi Arabia
  • Rest of LAMEA

Key Market Players:

• IDEXX Laboratories, Inc.
• Thermo Fisher Scientific Inc.
• Merck Group KGaA
• Pall Corporation
• Bio-Rad Laboratories, Inc.
• Abbott Laboratories
• Hygiena
• Veolia Water Technologies
• Pro-Lab Diagnostics
• Phigenics, LLC

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

• 1.1. Report Description
• 1.2. Key Market Segments
• 1.3. Key Benefits
• 1.4. Research Methodology
  • 1.4.1. Primary Research
  • 1.4.2. Secondary Research
  • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

• 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

• 3.1. Market Definition and Scope
• 3.2. Key Findings
  • 3.2.1. Top Investment Pockets
  • 3.2.2. Top Winning Strategies
• 3.3. Porter's Five Forces Analysis
  • 3.3.1. Bargaining Power of Suppliers
  • 3.3.2. Threat of New Entrants
  • 3.3.3. Threat of Substitutes
  • 3.3.4. Competitive Rivalry
  • 3.3.5. Bargaining Power among Buyers
• 3.4. Market Dynamics
  • 3.4.1. Drivers
  • 3.4.2. Restraints
  • 3.4.3. Opportunities

CHAPTER 4: LEGIONELLA TESTING KITS MARKET, BY TYPE

• 4.1. Market Overview
  • 4.1.1 Market Size and Forecast, By Type
• 4.2. Culture Media
  • 4.2.1. Key Market Trends, Growth Factors and Opportunities
  • 4.2.2. Market Size and Forecast, By Region
  • 4.2.3. Market Share Analysis, By Country
• 4.3. Urine Antigen Testing
  • 4.3.1. Key Market Trends, Growth Factors and Opportunities
  • 4.3.2. Market Size and Forecast, By Region
  • 4.3.3. Market Share Analysis, By Country
• 4.4. Polymerase Chain Reaction
  • 4.4.1. Key Market Trends, Growth Factors and Opportunities
  • 4.4.2. Market Size and Forecast, By Region
  • 4.4.3. Market Share Analysis, By Country
• 4.5. Serology
  • 4.5.1. Key Market Trends, Growth Factors and Opportunities
  • 4.5.2. Market Size and Forecast, By Region
  • 4.5.3. Market Share Analysis, By Country
• 4.6. Direct Fluorescent Antibody Test
  • 4.6.1. Key Market Trends, Growth Factors and Opportunities
  • 4.6.2. Market Size and Forecast, By Region
  • 4.6.3. Market Share Analysis, By Country

CHAPTER 5: LEGIONELLA TESTING KITS MARKET, BY END USER

• 5.1. Market Overview
  • 5.1.1 Market Size and Forecast, By End User
• 5.2. Hospitals And Clinics
  • 5.2.1. Key Market Trends, Growth Factors and Opportunities
  • 5.2.2. Market Size and Forecast, By Region
  • 5.2.3. Market Share Analysis, By Country
• 5.3. Clinical Laboratories
  • 5.3.1. Key Market Trends, Growth Factors and Opportunities
  • 5.3.2. Market Size and Forecast, By Region
  • 5.3.3. Market Share Analysis, By Country
• 5.4. Others
  • 5.4.1. Key Market Trends, Growth Factors and Opportunities
  • 5.4.2. Market Size and Forecast, By Region
  • 5.4.3. Market Share Analysis, By Country

CHAPTER 6: LEGIONELLA TESTING KITS MARKET, BY REGION

• 6.1. Market Overview
  • 6.1.1 Market Size and Forecast, By Region
• 6.2. North America
  • 6.2.1. Key Market Trends and Opportunities
  • 6.2.2. Market Size and Forecast, By Type
  • 6.2.3. Market Size and Forecast, By End User
  • 6.2.4. Market Size and Forecast, By Country
  • 6.2.5. U.S. Legionella Testing Kits Market
    • 6.2.5.1. Market Size and Forecast, By Type
    • 6.2.5.2. Market Size and Forecast, By End User
  • 6.2.6. Canada Legionella Testing Kits Market
    • 6.2.6.1. Market Size and Forecast, By Type
    • 6.2.6.2. Market Size and Forecast, By End User
  • 6.2.7. Mexico Legionella Testing Kits Market
    • 6.2.7.1. Market Size and Forecast, By Type
    • 6.2.7.2. Market Size and Forecast, By End User
• 6.3. Europe
  • 6.3.1. Key Market Trends and Opportunities
  • 6.3.2. Market Size and Forecast, By Type
  • 6.3.3. Market Size and Forecast, By End User
  • 6.3.4. Market Size and Forecast, By Country
  • 6.3.5. France Legionella Testing Kits Market
    • 6.3.5.1. Market Size and Forecast, By Type
    • 6.3.5.2. Market Size and Forecast, By End User
  • 6.3.6. Germany Legionella Testing Kits Market
    • 6.3.6.1. Market Size and Forecast, By Type
    • 6.3.6.2. Market Size and Forecast, By End User
  • 6.3.7. Italy Legionella Testing Kits Market
    • 6.3.7.1. Market Size and Forecast, By Type
    • 6.3.7.2. Market Size and Forecast, By End User
  • 6.3.8. Spain Legionella Testing Kits Market
    • 6.3.8.1. Market Size and Forecast, By Type
    • 6.3.8.2. Market Size and Forecast, By End User
  • 6.3.9. UK Legionella Testing Kits Market
    • 6.3.9.1. Market Size and Forecast, By Type
    • 6.3.9.2. Market Size and Forecast, By End User
  • 6.3.10. Rest of Europe Legionella Testing Kits Market
    • 6.3.10.1. Market Size and Forecast, By Type
    • 6.3.10.2. Market Size and Forecast, By End User
• 6.4. Asia-Pacific
  • 6.4.1. Key Market Trends and Opportunities
  • 6.4.2. Market Size and Forecast, By Type
  • 6.4.3. Market Size and Forecast, By End User
  • 6.4.4. Market Size and Forecast, By Country
  • 6.4.5. China Legionella Testing Kits Market
    • 6.4.5.1. Market Size and Forecast, By Type
    • 6.4.5.2. Market Size and Forecast, By End User
  • 6.4.6. Japan Legionella Testing Kits Market
    • 6.4.6.1. Market Size and Forecast, By Type
    • 6.4.6.2. Market Size and Forecast, By End User
  • 6.4.7. India Legionella Testing Kits Market
    • 6.4.7.1. Market Size and Forecast, By Type
    • 6.4.7.2. Market Size and Forecast, By End User
  • 6.4.8. South Korea Legionella Testing Kits Market
    • 6.4.8.1. Market Size and Forecast, By Type
    • 6.4.8.2. Market Size and Forecast, By End User
  • 6.4.9. Australia Legionella Testing Kits Market
    • 6.4.9.1. Market Size and Forecast, By Type
    • 6.4.9.2. Market Size and Forecast, By End User
  • 6.4.10. Rest of Asia-Pacific Legionella Testing Kits Market
    • 6.4.10.1. Market Size and Forecast, By Type
    • 6.4.10.2. Market Size and Forecast, By End User
• 6.5. LAMEA
  • 6.5.1. Key Market Trends and Opportunities
  • 6.5.2. Market Size and Forecast, By Type
  • 6.5.3. Market Size and Forecast, By End User
  • 6.5.4. Market Size and Forecast, By Country
  • 6.5.5. Brazil Legionella Testing Kits Market
    • 6.5.5.1. Market Size and Forecast, By Type
    • 6.5.5.2. Market Size and Forecast, By End User
  • 6.5.6. South Africa Legionella Testing Kits Market
    • 6.5.6.1. Market Size and Forecast, By Type
    • 6.5.6.2. Market Size and Forecast, By End User
  • 6.5.7. Saudi Arabia Legionella Testing Kits Market
    • 6.5.7.1. Market Size and Forecast, By Type
    • 6.5.7.2. Market Size and Forecast, By End User
  • 6.5.8. Rest of LAMEA Legionella Testing Kits Market
    • 6.5.8.1. Market Size and Forecast, By Type
    • 6.5.8.2. Market Size and Forecast, By End User

CHAPTER 7: COMPETITIVE LANDSCAPE

• 7.1. Introduction
• 7.2. Top Winning Strategies
• 7.3. Product Mapping of Top 10 Player
• 7.4. Competitive Dashboard
• 7.5. Competitive Heatmap
• 7.6. Top Player Positioning, 2023

CHAPTER 8: COMPANY PROFILES

• 8.1. IDEXX Laboratories, Inc.
  • 8.1.1. Company Overview
  • 8.1.2. Key Executives
  • 8.1.3. Company Snapshot
  • 8.1.4. Operating Business Segments
  • 8.1.5. Product Portfolio
  • 8.1.6. Business Performance
  • 8.1.7. Key Strategic Moves and Developments
• 8.2. Thermo Fisher Scientific
  • 8.2.1. Company Overview
  • 8.2.2. Key Executives
  • 8.2.3. Company Snapshot
  • 8.2.4. Operating Business Segments
  • 8.2.5. Product Portfolio
  • 8.2.6. Business Performance
  • 8.2.7. Key Strategic Moves and Developments
• 8.3. Merck Group KGaA
  • 8.3.1. Company Overview
  • 8.3.2. Key Executives
  • 8.3.3. Company Snapshot
  • 8.3.4. Operating Business Segments
  • 8.3.5. Product Portfolio
  • 8.3.6. Business Performance
  • 8.3.7. Key Strategic Moves and Developments
• 8.4. Pall Corporation
  • 8.4.1. Company Overview
  • 8.4.2. Key Executives
  • 8.4.3. Company Snapshot
  • 8.4.4. Operating Business Segments
  • 8.4.5. Product Portfolio
  • 8.4.6. Business Performance
  • 8.4.7. Key Strategic Moves and Developments
• 8.5. Bio-Rad Laboratories, Inc.
  • 8.5.1. Company Overview
  • 8.5.2. Key Executives
  • 8.5.3. Company Snapshot
  • 8.5.4. Operating Business Segments
  • 8.5.5. Product Portfolio
  • 8.5.6. Business Performance
  • 8.5.7. Key Strategic Moves and Developments
• 8.6. Abbott Laboratories
  • 8.6.1. Company Overview
  • 8.6.2. Key Executives
  • 8.6.3. Company Snapshot
  • 8.6.4. Operating Business Segments
  • 8.6.5. Product Portfolio
  • 8.6.6. Business Performance
  • 8.6.7. Key Strategic Moves and Developments
• 8.7. Hygiena
  • 8.7.1. Company Overview
  • 8.7.2. Key Executives
  • 8.7.3. Company Snapshot
  • 8.7.4. Operating Business Segments
  • 8.7.5. Product Portfolio
  • 8.7.6. Business Performance
  • 8.7.7. Key Strategic Moves and Developments
• 8.8. Veolia Water Technologies
  • 8.8.1. Company Overview
  • 8.8.2. Key Executives
  • 8.8.3. Company Snapshot
  • 8.8.4. Operating Business Segments
  • 8.8.5. Product Portfolio
  • 8.8.6. Business Performance
  • 8.8.7. Key Strategic Moves and Developments
• 8.9. Pro-Lab Diagnostics
  • 8.9.1. Company Overview
  • 8.9.2. Key Executives
  • 8.9.3. Company Snapshot
  • 8.9.4. Operating Business Segments
  • 8.9.5. Product Portfolio
  • 8.9.6. Business Performance
  • 8.9.7. Key Strategic Moves and Developments
• 8.10. Phigenics, LLC
  • 8.10.1. Company Overview
  • 8.10.2. Key Executives
  • 8.10.3. Company Snapshot
  • 8.10.4. Operating Business Segments
  • 8.10.5. Product Portfolio
  • 8.10.6. Business Performance
  • 8.10.7. Key Strategic Moves and Developments